XIFIN Blog Regulations

Follow Us
lale.white's picture

Termination of the BlueCard Program Runs Afoul of State and Federal Regulations

Submitted by lale.white on Tue, 2012-06-19 11:10
Tue, 2012-06-19 11:08
Blue plans attempting to reconcile the non-standard claims filing rules imposed by BCBS associated with the termination of the BlueCard program are running afoul of state and federal regulations; from non-adherence to HIPAA electronic standards to ignoring state assignment laws.
lale.white's picture

Who if anyone benefits from the dismantling of the BlueCard® program?

Submitted by lale.white on Tue, 2012-06-12 10:20
Tue, 2012-06-12 10:18
The new system turns a straightforward process into an unnecessarily complicated and expensive one. Is the BCBS Association, forcing the Blues to enforce their exclusivity arrangements that disadvantage regional labs and prohibit them from competing in the market place?
lale.white's picture

Action Alert: Petition to expand the NIH Public Access Policy across all U.S. Federal Science Agencies

Submitted by lale.white on Mon, 2012-05-21 10:24
Mon, 2012-05-21 10:22
To reach 25,000 signatures, we urge you to sign the petition at wh.gov/6TH today. Then do all that you can to activate your networks to do the same.
lale.white's picture

Labs "Very Nervous" About Palmetto GBA /CMS Contract, New Z-Codes and LCDs

Submitted by lale.white on Thu, 2011-11-03 10:29
Thu, 2011-11-03 10:28
Palmetto GBA announced that they obtained a new contract with CMS to develop a registry for Molecular diagnostic tests that would establish a new Z-code for each test using McKesson's proprietary software.
lale.white's picture

Increased Focus on Compliance Puts Pressure On Labs

Submitted by lale.white on Thu, 2011-10-13 11:15
Thu, 2011-10-13 11:13
With the government’s increased enforcement efforts and arsenal, the need for a comprehensive and highly effective compliance plan has never been greater. With the passage of PPACA in March 2010, a compliance program is now a legal requirement for providers participating in Medicare or Medicaid programs. A defined compliance program is also essential for clinical laboratories to survive and succeed, as well as for lab owners looking to exit the industry through a merger or acquisition.

Interested In Learning More? Contact us to learn how XIFIN can help your business. Call us at (858) 436-2995 or click here to complete a brief information request form.